Composition & method for altering levels of or sensitivity to adenosine with a dehydroepiandrosterone &/or a ubiquinone
US6670349B1 · kind B1 · utility
7Cited by
30References
70Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 20, 2000 |
| Grant date | Dec 30, 2003 |
| Priority date | — |
| Expiry date | Jan 20, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating adenosine depletion in a subject in need of such treatment is disclosed. The method comprises administering to the subject folinic acid or a pharmaceutically acceptable salt thereof in an amount effective to treat adenosine depletion. A method of treating asthma in a subject in need of such treatment is also disclosed. The method comprises administering to the subject dehydroepiandrosterone, analogs thereof, or pharmaceutically acceptable salts thereof in an amount effective to treat asthma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.